How is blood plasma turned into an infection-fighting drug?
Patients who have recovered from the disease have permanent antibodies generated by the immune system floating in their blood plasma, the liquid component of blood. To turn that into a drug, the plasma is harvested, tested for safety, and purified to isolate those protective antibodies. When injected into a new patient, the “plasma-derived therapy” — also known as convalescent plasma — provides “passive immunity” until the patient’s immune system can generate its own antibodies.
You are atleast 17 years old and weigh atleast 50 Kgs.
Have prior, verified diagnosis of COVID19, but are now symptom free and fully recovered since more than 10 days.